Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of F-18-PSMA-1007 vs F-18-Fluorocholine PET to Compare the Detection Rate of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer

NCT04102553 is registered in ClinicalTrials.gov with ABX advanced biochemical compounds GmbH as lead sponsor.

NCT NCT04102553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of F-18-PSMA-1007 vs F-18-Fluorocholine PET to Compare the Detection Rate of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer
Lead sponsor
ABX advanced biochemical compounds GmbH
Phase
Phase 3
Overall status
Completed
Start date
March 6, 2019
Completion date
March 19, 2021
Enrollment
200 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer recurrent